TMC Life Sciences Berhad

KLSE:TMCLIFE Stock Report

Market Cap: RM1.2b

TMC Life Sciences Berhad Balance Sheet Health

Financial Health criteria checks 5/6

TMC Life Sciences Berhad has a total shareholder equity of MYR877.0M and total debt of MYR208.9M, which brings its debt-to-equity ratio to 23.8%. Its total assets and total liabilities are MYR1.2B and MYR314.3M respectively. TMC Life Sciences Berhad's EBIT is MYR69.7M making its interest coverage ratio 12.8. It has cash and short-term investments of MYR190.3M.

Key information

23.8%

Debt to equity ratio

RM208.94m

Debt

Interest coverage ratio12.8x
CashRM190.34m
EquityRM877.02m
Total liabilitiesRM314.28m
Total assetsRM1.19b

Recent financial health updates

Recent updates

TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

Feb 14
TMC Life Sciences Berhad (KLSE:TMCLIFE) Seems To Use Debt Quite Sensibly

We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Sep 29
We Think TMC Life Sciences Berhad (KLSE:TMCLIFE) Can Stay On Top Of Its Debt

Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

Aug 26
Investors Met With Slowing Returns on Capital At TMC Life Sciences Berhad (KLSE:TMCLIFE)

TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

May 26
TMC Life Sciences Berhad (KLSE:TMCLIFE) Shareholders Will Want The ROCE Trajectory To Continue

TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 09
TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Jan 13
Returns On Capital - An Important Metric For TMC Life Sciences Berhad (KLSE:TMCLIFE)

Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Dec 22
Would Shareholders Who Purchased TMC Life Sciences Berhad's (KLSE:TMCLIFE) Stock Three Years Be Happy With The Share price Today?

Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Dec 02
Should You Use TMC Life Sciences Berhad's (KLSE:TMCLIFE) Statutory Earnings To Analyse It?

Financial Position Analysis

Short Term Liabilities: TMCLIFE's short term assets (MYR272.9M) exceed its short term liabilities (MYR97.0M).

Long Term Liabilities: TMCLIFE's short term assets (MYR272.9M) exceed its long term liabilities (MYR217.3M).


Debt to Equity History and Analysis

Debt Level: TMCLIFE's net debt to equity ratio (2.1%) is considered satisfactory.

Reducing Debt: TMCLIFE's debt to equity ratio has increased from 0.01% to 23.8% over the past 5 years.

Debt Coverage: TMCLIFE's debt is well covered by operating cash flow (46.4%).

Interest Coverage: TMCLIFE's interest payments on its debt are well covered by EBIT (12.8x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.